Art

J-GLOBAL ID：200902272531269391   Reference number：09A0461846

Anti-Glutamic Acid Decarboxylase Antibody in Graves’ Disease Is A Possible Indicator for The Unlikelihood of Going into Remission with Antithyroid Agents

Graves病における抗グルタミン酸デカルボキシラーゼ抗体は抗甲状腺剤による寛解入りの不可能性の指標になりえる

Author (4)： YOSHIHARA Ai (Dep. of Medicine, Inst. of Clinical Endocrinology, Tokyo Women’s Medical Univ.) ,  ISOZAKI Osamu (Dep. of Medicine, Inst. of Clinical Endocrinology, Tokyo Women’s Medical Univ.) ,  OKUBO Yumiko (Dep. of Medicine, Inst. of Clinical Endocrinology, Tokyo Women’s Medical Univ.) ,  TAKANO Kazue (Dep. of Medicine, Inst. of Clinical Endocrinology, Tokyo Women’s Medical Univ.)
Material： Endocrine Journal  (Endocr J)
Volume： 56  Issue： 2  Page： 269-274 (J-STAGE)  Publication year： 2009 
JST Material Number： F0625A  ISSN： 0918-8959  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： *goitrogen ,...
Semi thesaurus term： insulin-dependend diabetes mellitus ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=09A0461846&from=J-GLOBAL&jstjournalNo=F0625A") }}

JST classification (2)： Endocrine diseases  (GL03000I) ,  Biochemistry of antigens,antibodies,complements  (ED04020L)

Substance index (1)： Methimazole

Reference (14)：

• TURNER, R. UKPDS 25 : autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet. 1997, 350, 1288-1293
• LESLIE, RD. Autoantigens IA-2 and GAD in Type I (insulin-dependent) diabetes. Diabetologia. 1999, 42, 3-14
• BARKER, JM. Clinical review : Type 1 diabetes-associated autoimmunity : natural history, genetic associations, and screening. J Clin Endocrinol Metab. 2006, 91, 1210-1217
• KOBAYASHI, T. GAD antibodies seldom disappear in slowly progressive IDDM. Diabetes Care. 1996, 19, 1031
• HIROMATSU, Y. IL-18 gene polymorphism confers susceptibility to the development of anti-GAD65 antibody in Graves' disease. Diabet Med. 2006, 23, 211-215

Terms in the title (6)： Graves病 ,  グルタミン酸デカルボキシラーゼ ,  抗体 ,  甲状腺 ,  寛解 ,  指標